Additionally, CHI3L1 can predict the risk of non-alcoholic steatohepatitis, the progression of hepatic fibrosis, and the prognosis of alcoholic liver disease and hepatocellular carcinoma. This evidence concerns the gene CHI3L1 and metabolic dysfunction-associated steatohepatitis.